Quick Answer
Oric Pharmaceuticals, Inc. reported Common Stock Shares Outstanding of 98.53 million shares for the year ending 2025.
- Oric Pharmaceuticals, Inc. showed an increase of +38.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Oric Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 23, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Oric Pharmaceuticals, Inc.'s Common Stock Shares Outstanding has grown by 4,865.6%.
- Historical annual values: Fiscal year 2025: 98.53 million shares | Fiscal year 2024: 71.02 million shares | Fiscal year 2023: 54.87 million shares | Fiscal year 2022: 45.09 million shares | Fiscal year 2021: 39.43 million shares | Fiscal year 2020: 36.67 million shares | Fiscal year 2019: 1.98 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: